<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>35</o:Revision>
  <o:TotalTime>116</o:TotalTime>
  <o:Created>2003-11-05T17:21:00Z</o:Created>
  <o:LastSaved>2003-11-07T15:46:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>503</o:Words>
  <o:Characters>2872</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>23</o:Lines>
  <o:Paragraphs>5</o:Paragraphs>
  <o:CharactersWithSpaces>3527</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>150</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-indent:36.0pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	text-autospace:none;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	text-decoration:underline;
	text-underline:single;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	text-autospace:none;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{margin:0cm;
	margin-bottom:.0001pt;
	text-indent:36.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1030"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/index.html"
title="To InterPro database"><span style='text-decoration:none;text-underline:
none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page2_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page2_files/image001.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;font-family:"Times New Roman";color:navy'>SV40<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=284 valign=top style='width:213.05pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_i1026" type="#_x0000_t75"
   style='width:170.25pt;height:283.5pt'>
   <v:imagedata src="./Page2_files/image002.jpg" o:title="SV40_transformation3"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=227 height=378
  src="./Page2_files/image003.jpg" v:shapes="_x0000_i1026"><![endif]></p>
  </td>
  <td width=284 valign=top style='width:213.05pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoCaption style='text-indent:0cm'>SV40 and the pathogenesis of
  mesothelioma</p>
  <p class=MsoNormal>Diagram shows an <i>in vitro</i> transformation model, where
  asbestos and SV40 large-T Ag are acting as co-carcinogens.<span
  style="mso-spacerun: yes">  </span>T-Ag is shown to block p53, RB and
  RASSF1A, and upregulate Notch1 and MET oncogenes.</p>
  <p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><span
  style='font-size:10.0pt'>Reprinted by permission from <a
  href="http://www.nature.com/reviews/" title="Nature Reviews"><span
  style='text-decoration:none;text-underline:none'>Nature Reviews</span></a>
  Cancer 2:957-964, A. Gazdar, J. S. Butel and M. Carbone <o:p></o:p></span></p>
  <p class=MsoBodyText>&quot;SV40 and tumours: myth, association or
  causality?&quot; copyright (2002) Macmillan Magazines Ltd</p>
  <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><a
  href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12459734&amp;dopt=Abstract"
  title="Gazdar A, Butel JS, Carbone M (2002) Nat. Rev. Cancer 2:957-964. SV40 and tumours: myth, association or causality?">PMID:
  12459734</a><span style='color:navy'><o:p></o:p></span></p>
  <p class=MsoNormal style='mso-layout-grid-align:none;text-autospace:none'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
</table>

<h1><span style='font-size:10.0pt;mso-bidi-font-size:16.0pt;color:navy'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></h1>

<h1><span style='color:navy'>SV40 and cancer<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Several
viruses have been implicated in the pathogenesis of different cancers, including
papillomavirus, Epstein-Barr virus, hepatitis B virus and HIV-1.<span
style="mso-spacerun: yes">  </span>The study of tumour-promoting viruses has
greatly increased our understanding of cancer pathology.<span
style="mso-spacerun: yes">  </span>SV40 has been found in various tumour types,
including brain tumours, bone tumours, mesotheliomas and non-Hodgkin’s
lymphomas, suggesting that SV40 maybe a transforming virus under certain
circumstances.<span style="mso-spacerun: yes">  </span>All these tumour-types
can be induced with SV40 in laboratory animals.</p>

<p class=MsoBodyTextIndent>The SV40 small-t Ag and large-T Ag are considered to
be oncoproteins under certain conditions, and together they can transform cells
in culture.<span style="mso-spacerun: yes">  </span>The transformation of
cultured cells requires both the stimulation of cell division and the blocking
cell apoptosis; the large-T Ag can bring both of these functions about.</p>

<p class=MsoNormal style='text-indent:36.0pt'>The large-T Ag is a
multifunctional protein concerned with a wide range of cellular processes,
including transcriptional activation and repression, blocking of
differentiation, stimulation of the cell cycle, repression of apoptosis and
cell transformation.<span style="mso-spacerun: yes">  </span>The large-T Ag has
three domains: a DnaJ domain (acts as a molecular chaperone), a RB-binding
domain and a p53-binding domain, while the small-t Ag has the DnaJ domain and a
serine/threonine phosphatase PP2A-binding domain.<span style="mso-spacerun:
yes">  </span>The large-T Ag gains control of the cell through its interactions
with cellular proteins such as p53, RB (retinoblastoma), p107, p130, CBP/p300,
and RASSF1A.<span style="mso-spacerun: yes">  </span>The large-T Ag is able to
disrupt both the RB and the p53 tumour suppressor pathways by binding and
inactivating the cell cycle control proteins RB and p53, which stimulates the
host cell to enter S phase and undergo DNA synthesis.<span style="mso-spacerun:
yes">  </span>RB acts to arrest cells in the G1 phase of cell division by
repressing the transcription of genes required for entry into S phase, while
p53 controls an apoptosis pathway; by inactivating both these proteins, the
large-T Ag is able to stimulate cell division and block apoptosis.</p>

<p class=MsoNormal style='text-indent:36.0pt'>The small-t Ag acts to transform
cell by binding to PP2A, an abundant family of serine-threonine
phosphatases.<span style="mso-spacerun: yes">  </span>The loss of PP2A activity
is thought to cause defects in the biogenesis and properties of tight
junctions, leading to the disorganisation of the actin cytoskeleton.<span
style="mso-spacerun: yes">  </span>PP2A loss also causes the deregulation of
Rho GTPases, F-actin and intercellular adhesion.<span style="mso-spacerun:
yes">  </span>Defects in the actin cytoskeleton and the disruption of tight
junctions have been linked to tumour invasiveness.</p>

<p class=MsoNormal style='text-indent:36.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'>Next:<span style="mso-spacerun:
yes">  </span><a href="Page3.htm">What InterPro tells us</a></h1>

<h1 align=center style='text-align:center'>Previous:<span style="mso-spacerun:
yes">  </span><a href="Page1.htm">Architecture of a virus</a><span
style='font-weight:normal'><o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
